WallStreetZenWallStreetZen

Insurance Provider Hci Group Sees Strong Buy Rating and Price Target Hike

By Don Francis, Editor
November 9, 2023 6:42 AM UTC
Insurance Provider Hci Group Sees Strong Buy Rating and Price Target Hike

Truist Securities's Mark Hughes raised their price target on Hci Group (NYSE: HCI) by 20% from $80 to $96 on 2023/11/08. The analyst maintained their Strong Buy rating on the stock.

In support of their price target hike, Hughes highlighted from Hci Group's Q3 2023 earnings report, issued on 2023/11/07, that "the company's upside in Q3 results along with an incremental contribution from the Citizens takeouts in Q4." This positive outlook reflects the analyst's confidence in the company's performance and the potential impact of strategic initiatives.

Hci Group, a property and casualty insurance provider in Florida, reported impressive financials for Q3 2023. The company's earnings per share (EPS) of $1.41 exceeded the Zacks Consensus Estimate of $0.36 by a significant margin of 125.1%. It also marked a substantial improvement compared to Q3 2022's loss per share of $5.62. Additionally, Hci Group's revenue for the quarter stood at $131.64 million, surpassing the Zacks Consensus Estimate of $123.73 million by 3.9% and outperforming the previous year's Q3 revenue of $126.65 million.

Chairman and CEO Paresh Patel commented on the company's strong performance, attributing it to an improved operating environment in Florida and rising interest rates on their interest-bearing investments. Patel also noted the positive impact of recent insurance reforms enacted by the Florida Legislature, leading to improved loss ratios and a stabilized homeowners insurance market with greater choice and competition. As a result, Hci Group is expanding its Florida insurance businesses, including assuming policies from Citizens.

Truist Securities analyst Mark Hughes further justified their price target increase by boosting the FY 2024 EPS estimate on Hci Group from $4.85 to $11.50. This upward revision reflects expectations of improved underlying profitability and the positive influence of the Citizens takeouts.

Notably, Hci Group's positive outlook has garnered strong support from analysts overall. 100% of top-rated analysts currently rate the stock as a Strong Buy or Buy. No analysts see it as a Hold, and none recommend or strongly recommend selling the stock. This consensus reflects the market's optimism about Hci Group's future prospects.

In addition to Hci Group, Hughes also raised their price target on another insurance company, Skyward Specialty Insurance Group Inc, by 14.3%, from $35 to $40, while maintaining a Strong Buy rating. This suggests that Hughes sees growth potential in the insurance sector overall.

Year-over-year, Hci Group's stock has shown remarkable growth, with an 80.5% increase. During the same period, the stock has outperformed the S&P 500, which has risen by 15.1%. This strong performance further reinforces the positive sentiment surrounding Hci Group.

Truist Securities analyst Mark Hughes has an impressive track record, ranking in the top 3% of Wall Street analysts according to WallStreetZen. With an average return of 18.6% and a win rate of 66.7%, Hughes specializes in the Financial Services, Energy, and Healthcare sectors. This expertise lends credibility to the price target and rating provided for Hci Group.

Is HCI a Buy, Hold or Sell?

WallStreetZen tracks the performance of nearly 4,000 Wall Street analysts, whom we rank by average returns, frequency, and win-rate (backtested over multiple years).

Create a free watchlist and be the first to know when top-rated Wall Street analysts revise their HCI price target.

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen and Don Francis do not hold any positions in the companies mentioned in this article. The information and statistics provided herein are presented for general informational purposes only and may not be accurate, complete, or up-to-date. It should not be interpreted as a recommendation to buy or sell any stocks and should not be solely relied upon for making investment decisions. It does not take into account your financial situation or risk profile. All investors should conduct their own investment due diligence before buying a stock. WallStreetZen expressly disclaims any liability for the accuracy, reliability, or completeness of the analysts' information, price targets, ratings, or opinions.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.